AnaptysBio (ANAB) Soars 2.86% on Two Sigma Stake Increase

AnaptysBio (ANAB) surged 2.86%, marking its fifth consecutive day of gains, with a 14.93% increase over the past five days. The share price reached its highest level since October 2024 today, with an intraday gain of 3.51%.

The strategy of buying ANAB shares after they reached a recent high and selling them one week later delivered moderate returns but came with significant volatility and risk. The strategy’s CAGR was 11.37%, with a total return of 30.95%. It underperformed the benchmark, which had a return of -100.00%, indicating that the strategy’s absolute returns were not impressive. However, the strategy had a maximum drawdown of 0.00%, a Sharpe ratio of 0.17, and a volatility of 68.57%, suggesting that while the strategy minimized losses, it also came with considerable uncertainty and market swings.

Two Sigma Advisers LP recently increased its stake in AnaptysBio, Inc. (NASDAQ:ANAB), which could have contributed to the rise in ANAB's stock price. This move by a prominent investment firm suggests a positive outlook on the company's future prospects, potentially driving investor confidence and leading to the recent stock price appreciation.